Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 2 minute read Pharma Industry News Sumitovant Biopharma to take full ownership of Myovant Sciences for $1.7bn Sumitovant Biopharma, a subsidiary of Japan-based Sumitomo Pharma (previously Sumitomo Dainippon Pharma), is set to take full ownership… byPallavi MadhirajuOctober 24, 2022